Directorate Change

RNS Number : 4387Y
Deltex Medical Group PLC
03 September 2009
 



Deltex Medical Group plc


Directorate Change


3 September 2009 - Deltex Medical Group plc ('Deltex Medical' or 'Company'), the global leader in oesophageal Doppler monitoring ('ODM'), today announces that Paul Mitchell has been appointed Finance Director with immediate effect. 


Mr Mitchell joined Deltex Medical in August 2002 as Financial Controller, after qualifying as a Chartered Accountant with PricewaterhouseCoopers. In November 2004 he was appointed Company Secretary. 


Mr Mitchell currently holds 615,000 options under the Group's ESOP scheme and 127,660 under the Group's Enterprise Management Incentive Scheme as follows:

Name

No. of options

Exercise Price £

Exercise period from

Exercise period to

Executive Share Option Scheme

12,000

0.25

27 November 2005

26 November 2012


    28,000

0.15

28 October 2006

27 October 2013

 

100,000

0.24

12 October 2007

11 October 2014


100,000

0.2075

28 March 2009

27 March 2016


125,000

0.295

29 June 2010

28 June 2017


125,000

0.185

1 July 2011

30 June 2018


125,000

0.1275

12 June 2012

11 June 2019






EMI Scheme

127,660

0.01

12 June 2009

11 June 2019


Save as disclosed below, there are no other details regarding Paul Mitchell that are required to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules. 

Age

36 years

Directorships: current and held in the past five years.

Deltex Medical Limited

Deltex Medical (Chichester) Limited

Deltex Medical GmbH

Deltex Medical, SC Inc

Deltex Medical, Espana SL





For further information, please contact:-


Deltex Medical Group plc           01243 774 837

Nigel Keen, Chairman                    njk@deltexmedical.com

Ewan Phillips, Chief Executive        eap@deltexmedical.com 

Paul Mitchell, Finance Director       pjm@deltexmedical.com


Nominated Adviser & Broker

Arden Partners plc                     020 7398 1600

Christopher Hardie                        chris.hardie@arden-partners.com

Matthew Armitt                             matthew.armitt@arden-partners.com


Kreab Gavin Anderson               020 7554 1400

Deborah Walter                            dwalter@kreabgavinanderson.com

Robert Speed                               rspeed@kreabgavinanderson.com




This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABRGDCGBGGGCD
UK 100

Latest directors dealings